iNOS antibody - Orthogonal Validated

Catalog number: GTX130246_25ul
Brand: GeneTex
Packing: 25 ul
Other sizes: 100 ul
Price: € 151.00
Expected delivery time: 10 days
GTX130246 IHC-P Image
iNOS antibody detects iNOS protein ...
GTX130246 ICC/IF Image
iNOS antibody detects iNOS protein ...
GTX130246 WB Image
Untreated (–) and treated (+) Raw26...

Product specifications for - iNOS antibody - Orthogonal Validated

Product group: Antibodies
Category: Primary Antibodies
Application: ICC/IF, IHC-P, Western Blot
Species: Mouse, Rat
Host: Rabbit
Target: Nos2
Target description: nitric oxide synthase 2, inducible
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Storage instructions: Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
Scientific information: 
Gene ID: 18126
Swiss prot ID: P29477
Additional information: 
Synonyms: GTX130246; MAC-NOS; NOS-II; Nos-2; Nos2a; i-NOS; iNOS; nitric oxide synthase, inducible; NOS type II; inducible NO synthase; inducible NOS; inducible nitric oxide synthase; macrophage NOS; nitric oxide synthase 2, inducible, macrophage; peptidyl-cysteine S-nitrosylase NOS2
Yang YC, "Topoisomerase II-mediated DNA cleavage and mutagenesis activated by nitric oxide underlie the inflammation-associated tumorigenesis". Antioxid Redox Signal 18 (10), page 1129-40. Read more
Mei S, "MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression". PLoS One 10 (8), page e0135867. Read more
Lin WC, "Anti-inflammatory activity of Sanghuangporus sanghuang by suppressing the TLR4-mediated PI3K/AKT/mTOR/IKKβ signaling pathway". RSC Adv. 7, page 21234-21251. Read more
Zhao X, "PI3K/Akt signaling pathway modulates influenza virus induced mouse alveolar macrophage polarization to M1/M2b". PLoS One 9 (8), page e104506. Read more
Chao W, "3, 4-dihydroxybenzalacetone attenuates lipopolysaccharide-induced inflammation in acute lung injury via down-regulation of MMP-2 and MMP-9 activities through suppressing ROS-mediated MAPK and PI3K/AKT signaling pathways". Int Immunopharmacol 50, page 77-86. Read more